In a 47-year-old patient with alcohol use disorder, cirrhosis, recent variceal bleed status post banding, presenting with altered mental status, elevated blood urea nitrogen, acute kidney injury (creatinine 2.7 mg/dL), elevated lactate, hemoglobin 10 g/dL, and a normal head computed tomography, what is the appropriate management?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 29, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Immediate Management: Hepatic Encephalopathy and Hepatorenal Syndrome-AKI

This patient requires urgent treatment for hepatic encephalopathy (HE) and hepatorenal syndrome-acute kidney injury (HRS-AKI) with immediate albumin resuscitation, lactulose initiation, vasoconstrictor therapy (terlipressin or norepinephrine plus albumin), and evaluation for rebleeding.

Initial Diagnostic Approach

The altered mental status in this cirrhotic patient with recent variceal bleeding, elevated BUN:creatinine ratio (>20:1), and elevated lactate suggests two concurrent life-threatening complications:

  1. Hepatic encephalopathy - likely precipitated by the GI bleed (protein load from blood)
  2. HRS-AKI - evidenced by creatinine 2.7 mg/dL (>1.5x baseline presumed) with ascites

The normal CT head appropriately excludes intracranial hemorrhage (important in alcohol use disorder patients who have >5-fold increased risk of intracerebral bleeding) 1.

Priority 1: Assess for Ongoing/Recurrent Variceal Bleeding

  • Check for hemodynamic instability (tachycardia, hypotension)
  • Examine for melena or hematemesis
  • The hemoglobin of 10 g/dL with elevated lactate (5) and BUN:Cr ratio of 21:1 suggests either:
    • Active bleeding with hypoperfusion
    • Recent significant blood loss with prerenal azotemia
    • HRS-AKI with upper GI bleeding as precipitant

If active bleeding suspected: Urgent upper endoscopy, blood transfusion to Hgb 7-9 g/dL (not higher), octreotide infusion, and prophylactic antibiotics 2.

Priority 2: Treat Hepatic Encephalopathy

The altered mental status with recent GI bleed in cirrhosis is HE until proven otherwise:

  • Lactulose: Start immediately at 20-30g orally/NG every 1-2 hours until bowel movement, then titrate to 2-3 soft stools daily 1
  • Rifaximin: Add 550 mg twice daily if available
  • Identify and treat precipitants:
    • GI bleeding (protein load) - already identified
    • Infection - obtain blood cultures, urinalysis, diagnostic paracentesis for spontaneous bacterial peritonitis
    • Constipation - address with lactulose
    • Medications - review for sedatives, opioids

The elevated ammonia drives both HE and contributes to poor prognosis in acute-on-chronic liver failure 1.

Priority 3: Manage HRS-AKI

This patient meets HRS-AKI criteria 3:

  • Cirrhosis with ascites
  • Creatinine 2.7 mg/dL (>1.5x baseline or >0.3 mg/dL increase within 48h)
  • No shock (presumably)
  • Recent nephrotoxic insult (hypoperfusion from bleeding)

Immediate Steps:

Volume assessment and albumin challenge 3:

  • Discontinue diuretics immediately
  • Give albumin 1 g/kg/day (maximum 100g) for 2 consecutive days
  • Monitor for volume overload (risk of pulmonary edema with excessive albumin) 3

If no response after 48 hours of albumin (creatinine remains elevated):

Initiate vasoconstrictor therapy - Choose based on availability and contraindications:

  1. Terlipressin (preferred if available) 3, 4:

    • First FDA-approved drug for HRS-AKI
    • Dose: 1 mg IV every 4-6 hours, increase to 2 mg every 4-6 hours if inadequate response after 3 days
    • Contraindications: Creatinine ≥5 mg/dL, oxygen saturation <90%
    • Continue albumin 20-40 g/day
    • Monitor for ischemic complications (angina, digital/intestinal ischemia)

  2. Norepinephrine (if terlipressin unavailable or contraindicated) 3:

    • Start 0.5 mg/h continuous IV infusion
    • Increase by 0.5 mg/h every 4 hours (maximum 3 mg/h)
    • Goal: Increase MAP by ≥10 mm Hg and/or urine output >50 mL/h for ≥4 hours
    • Continue albumin 20-40 g/day
    • Requires ICU monitoring

  3. Midodrine + Octreotide (alternative, less effective) 3:

    • Midodrine: Start 7.5 mg PO TID, titrate to 12.5 mg TID
    • Octreotide: 100 mcg SC TID, titrate to 200 mcg TID
    • Continue albumin

Priority 4: Rule Out Other AKI Causes

Obtain urinalysis 3:

  • Proteinuria >500 mg/day suggests structural kidney disease (not HRS)
  • Hematuria >50 RBCs/hpf suggests structural kidney disease
  • Muddy brown casts suggest acute tubular necrosis (ATN)

Renal ultrasound 3: Rule out obstruction (should be normal in HRS)

Diagnostic paracentesis 5: Rule out spontaneous bacterial peritonitis (present in 25% of decompensated cirrhosis, can precipitate both HE and AKI)

Priority 5: Address Elevated Lactate

Lactate of 5 indicates tissue hypoperfusion from:

  • Hypovolemia from bleeding
  • Reduced effective arterial blood volume (cirrhosis pathophysiology)
  • Possible sepsis (check for infection)
  • Abdominal compartment syndrome from tense ascites 6

Measure intra-abdominal pressure if tense ascites present - abdominal perfusion pressure (APP) <60 mm Hg independently predicts AKI and mortality 6. Consider large-volume paracentesis if APP reduced.

Critical Pitfalls to Avoid

  • Do not delay vasoconstrictor therapy - early initiation improves HRS-AKI reversal rates 4
  • Do not over-transfuse - target Hgb 7-9 g/dL in variceal bleeding, not higher
  • Do not continue diuretics - worsens prerenal physiology
  • Do not use nephrotoxic agents - avoid NSAIDs, aminoglycosides, contrast
  • Do not start RRT prematurely - only indicated if: (1) ATN confirmed, (2) transplant candidate with HRS-AKI not responding to vasoconstrictors, or (3) urgent metabolic indication 3
  • Monitor for pulmonary edema - albumin therapy carries this risk 3

Disposition and Prognosis

  • ICU admission required for vasoconstrictor therapy and close monitoring
  • Liver transplant evaluation urgently if not already listed - transplantation is the only definitive treatment for HRS-AKI 3
  • Mortality risk is very high - AKI in cirrhosis carries 7-fold increased mortality 7, and HRS-AKI specifically has especially poor prognosis 8

The combination of recent variceal bleeding, HE, and HRS-AKI suggests acute-on-chronic liver failure with multi-organ dysfunction requiring aggressive intervention and transplant consideration 5.

References

7
Research

Acute Kidney Injury in Patients with Liver Disease.

Clinical journal of the American Society of Nephrology : CJASN, 2022

Related Questions

How can I create a concise assessment and plan note for a 47-year-old man with alcohol-related cirrhosis, recent variceal hemorrhage treated with endoscopic band ligation, grade 3‑4 hepatic encephalopathy, acute kidney injury consistent with hepatorenal syndrome, anemia, and a normal head CT?
In a 65-year-old man with cirrhosis due to chronic hepatitis C presenting with worsening ascites, oliguria, hypotension, hyponatremia, rapidly rising serum creatinine, very low urinary sodium, ascitic fluid not meeting spontaneous bacterial peritonitis criteria, and a normal renal ultrasound while on furosemide and spironolactone, what is the most likely diagnosis: acute interstitial nephritis, acute glomerulonephritis, acute tubular necrosis, or hepatorenal syndrome?
In a 72-year-old man with chronic kidney disease and alcohol abuse who presents with chronic digital swelling, what is the most likely diagnosis?
In a patient with chronic kidney disease and ascites presenting with oliguria, is the cause acute tubular necrosis (ATN) (tubular injury), a pre‑renal process, a primary renal disease, or a post‑renal obstruction?
What is the recommended albumin infusion dosing and monitoring for an adult with advanced cirrhosis and acute kidney injury suspected of hepatorenal syndrome?
What are the appropriate treatment options for perimenopausal symptoms in a 46‑year‑old woman with a prior cerebrovascular accident (stroke) secondary to carotid artery stenosis?
What is the urgent evaluation and management for posterior ischemic optic neuropathy?
Given negative anti‑dsDNA, anti‑Ro/SSA, anti‑Sm, anti‑La/SSB, and anti‑Jo‑1 antibodies, normal complement C3 and C4, a history of positive anti‑U1 RNP, elevated creatine kinase, mildly reduced estimated glomerular filtration rate, and glucose‑6‑phosphate dehydrogenase deficiency, what symptomatic treatments are safe to use while I wait for my rheumatology appointment in eight days?
What is the appropriate amikacin dose for a 2‑month‑old infant weighing 3.5 kg?
What is the recommended next step in management for a patient with a left axillary lymph node identified on revision surgery at the base of the tumor cavity in a high‑grade (Fédération Nationale des Centres de Lutte contre le Cancer grade 3) undifferentiated pleomorphic sarcoma?
What is a hemangioma, explained in layman's terms?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.